Brexpiprazole for the Treatment of Tics in a Patient With Schizophrenia
The Primary Care Companion For CNS Disorders · 2023
DOI: 10.4088/pcc.22cr03415 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Primary Care Companion For CNS Disorders, 2023. Verfasst von Chu-Syuan Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Schizophrenia, Tics, Quinolones, Antipsychotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei City, Taiwan.
- Corresponding Author: Chu-Syuan Cheng, MD, Department of General Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, No 309, Songde Rd, Taipei 110, Taipei City, Taiwan (b00401067@ntu.edu.tw).
Zitieren
APA
Cheng, C. S., Lin, S. K., & Kuo, C. J. (2023). Brexpiprazole for the Treatment of Tics in a Patient With Schizophrenia. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.22cr03415
Vancouver
Cheng CS, Lin SK, Kuo CJ. Brexpiprazole for the Treatment of Tics in a Patient With Schizophrenia. The Primary Care Companion For CNS Disorders. 2023. doi:10.4088/pcc.22cr03415
BibTeX
@article{Cheng2023,
author = {Cheng, Chu-Syuan and Lin, Shi-Kwang and Kuo, Chian-Jue},
title = {Brexpiprazole for the Treatment of Tics in a Patient With Schizophrenia},
journal = {The Primary Care Companion For CNS Disorders},
year = {2023},
doi = {10.4088/pcc.22cr03415}
}
EUVIMED